美通社

SHANGHAI, May 2, 2024 /PRNewswire/ — Everest Medicines announced that the Hong Kong Department of Health had approved Nefecon® for the treatment of primary immunoglobulin A nephropathy in adults at risk of disease progression. Hong Kong marks the fourth region in Everest territories

SYDNEY, May 2, 2024 /PRNewswire/ — ATFX, a leading global online trading broker, is pleased to announce that Nick Twidale has joined the company as Chief Market Analyst for the Australia region. With over two decades of experience in banking and broking, Nick brings a wealth of expertise and leadership

香港2024年5月2日 /美通社/ — 香港領先的ETF發行商睿亞資產宣佈，即日起降低P…

HONG KONG, May 2, 2024 /PRNewswire/ — Premia Partners, a leading ETF provider from Hong Kong, announces today fee reduction of its Premia Vietnam ETF and change of the underlying index to S&P Vietnam Core Index NTR with immediate effect. Total expense ratio of the